COBE HEMOCONCENTRATOR 1.3— 510(k) K823338

Name: FDA 510(k) clearance K823338
Creator: U.S. Food and Drug Administration
Published: 1983-01-07

Substantially Equivalent

Cobe Laboratories, Inc.

FDA 510(k) clearance K823338 for COBE HEMOCONCENTRATOR 1.3, Substantially Equivalent on 1983-01-07. Applicant: Cobe Laboratories, Inc.. Device class: 2.

Clearance details

Applicant: Cobe Laboratories, Inc.
Product code: Code KDI
Device class: Class 2
Regulation: 21 CFR 876.5860
Advisory panel: Gastroenterology, Urology
Date received: 1982-11-08
Decision date: 1983-01-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KDI

view all

K261267 — Careflux H60; Careflux H70; Careflux V5002026-07-24
K252377 — NxStage System One with NxView2026-05-15
K260533 — ELISIO-H2026-03-19
K252459 — multiFlux 130 (F00013123); multiFlux 160 (F00013124)2026-02-10
K253412 — Tablo Hemodialysis System (PN-0008000, PN-0006000U)2026-01-26

More clearances from Cobe Laboratories, Inc.

view all

K923272 — COBE CMS-HF HOLLOW FIBER MEMBRANE OXYGENATOR1993-05-11
K900105 — COBE SPECTRA BLOOD COMPONENT SEPARATOR THERAPEUTIC1991-03-22
K905793 — COBE CENTRY 2 BICART OPTION KIT1991-02-12
K905388 — COBE CENTRYSYSTEM 3 BICART OPTION KIT1991-02-11
K904336 — NEW COBE SATURATION/HEMATOCRIT MONITOR1990-12-27

Adverse events under product code KDI

product code KDI

Death: 352
Injury: 1,474
Malfunction: 12,534
Other: 4
Total: 14,364

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.